Loading...
•
Sep 30, 2023
Zimmer Biomet Q3 2023 Earnings Report
Zimmer Biomet reported strong revenue growth and earnings per share.
Key Takeaways
Zimmer Biomet announced third quarter net sales of $1.754 billion, an increase of 5.0% over the prior year period, and an increase of 4.7% on a constant currency basis. Diluted earnings per share were $0.77 for the third quarter, and adjusted diluted earnings per share were $1.65.
Third quarter net sales of $1.754 billion increased 5.0% and 4.7% on a constant currency basis
Third quarter diluted earnings per share were $0.77; adjusted diluted earnings per share were $1.65
The Company updates 2023 reported revenue guidance due to currency expectations and reaffirms 2023 constant currency revenue growth and adjusted earnings per share financial guidance
Appointment of Ivan Tornos as President and Chief Executive Officer
Zimmer Biomet
Zimmer Biomet
Zimmer Biomet Revenue by Segment
Revenue by Segment
Knees Revenue
CapyFin.comHips Revenue
CapyFin.comS.E.T. Revenue
CapyFin.comTech/Data/Surgical Revenue
CapyFin.com Forward Guidance
The Company is updating its full-year 2023 financial guidance to modify the expected foreign currency exchange impact and is reaffirming constant currency revenue growth as well as adjusted EPS guidance
Revenue & Expenses
Visualization of income flow from segment revenue to net income